Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP20-2 Inhibitors

KRTAP20-2 inhibitors are a specialized class of chemical compounds that function by targeting keratin-associated protein 20-2 (KRTAP20-2), a member of the keratin-associated protein family. These proteins are integral to the structure and function of hair, nails, and other keratinized tissues, as they interact with keratin intermediate filaments to stabilize and maintain the rigidity of these structures. KRTAP20-2 plays a role in the assembly of hair fibers, contributing to their mechanical properties. Inhibitors of KRTAP20-2, therefore, work by disrupting this interaction, leading to modifications in the architecture and behavior of keratinized tissues, specifically within hair fiber formation.

Structurally, KRTAP20-2 inhibitors typically exhibit a high degree of specificity towards their target, often designed to interfere with the protein's conformation or its ability to bind keratin filaments. This specificity arises from interactions with key residues in the KRTAP20-2 protein that are crucial for its function. The chemical frameworks of these inhibitors vary, but they usually contain functional groups capable of forming hydrogen bonds or engaging in hydrophobic interactions with the target protein, enabling strong and selective binding. Research into KRTAP20-2 inhibitors often focuses on understanding the molecular mechanisms underlying these interactions and the effects of inhibition on keratinized tissue properties at a biochemical and structural level.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate could decrease KRTAP20-2 expression by disrupting folate metabolism and DNA synthesis, which are necessary for the transcription and replication of genetic material, including that of KRTAP20-2.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea may inhibit KRTAP20-2 expression by reducing the pool of deoxyribonucleotides, leading to a halt in DNA replication and repair mechanisms, which in turn could suppress transcriptional processes including those of KRTAP20-2.